Celldex Therapeutics, Inc. (CLDX)

NCM – Real Time Price. Currency in USD

44.60

+0.27 (0.61%)

Market open: Aug 12, 2026, 12:50 PM EDT

44.33

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

07.08.2026

Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates

Celldex Therapeutics (CLDX) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $0.85 per share a year ago.

Videos

No Data

There is no data to display

Celldex Therapeutics, Inc. (CLDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates

Videos

No Data

Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates

Videos

No Data

Search stocks

Celldex Therapeutics, Inc. (CLDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates

Videos

No Data

Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates

Videos

No Data